Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder

NCT02431806 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT02431806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02431806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Lead sponsor
Forest Laboratories
Phase
Phase 3
Overall status
Completed
Start date
June 23, 2015
Completion date
August 19, 2019
Enrollment
552 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder